P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38%
Updated: May 29, 2024

Operating Margin
Pear Therapeutics Inc

-923%
Current
-2 194%
Average
4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-923%
=
Operating Profit
-117.2m
/
Revenue
12.7m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
US
Pear Therapeutics Inc
NASDAQ:PEAR
1.1m USD
-923%
US
Veeva Systems Inc
NYSE:VEEV
32.8B USD
18%
US
Cerner Corp
NASDAQ:CERN
27.9B USD
13%
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD
3%
AU
Pro Medicus Ltd
ASX:PME
12.1B AUD
69%
JP
M3 Inc
TSE:2413
1T JPY
26%
US
Doximity Inc
NYSE:DOCS
5.3B USD
36%
US
Inspire Medical Systems Inc
NYSE:INSP
4.7B USD
-5%
SE
Sectra AB
STO:SECT B
45.2B SEK
-39%
US
Vocera Communications Inc
NYSE:VCRA
2.8B USD
0%
US
Goodrx Holdings Inc
NASDAQ:GDRX
2.7B USD
-4%
P
Pear Therapeutics Inc
NASDAQ:PEAR
Country US
Market Cap 1.1m USD
Operating Margin
-923%
Veeva Systems Inc
NYSE:VEEV
Country US
Market Cap 32.8B USD
Operating Margin
18%
Cerner Corp
NASDAQ:CERN
Country US
Market Cap 27.9B USD
Operating Margin
13%
Change Healthcare Inc
NASDAQ:CHNG
Country US
Market Cap 9B USD
Operating Margin
3%
Pro Medicus Ltd
ASX:PME
Country AU
Market Cap 12.1B AUD
Operating Margin
69%
M3 Inc
TSE:2413
Country JP
Market Cap 1T JPY
Operating Margin
26%
Doximity Inc
NYSE:DOCS
Country US
Market Cap 5.3B USD
Operating Margin
36%
Inspire Medical Systems Inc
NYSE:INSP
Country US
Market Cap 4.7B USD
Operating Margin
-5%
Sectra AB
STO:SECT B
Country SE
Market Cap 45.2B SEK
Operating Margin
-39%
Vocera Communications Inc
NYSE:VCRA
Country US
Market Cap 2.8B USD
Operating Margin
0%
Goodrx Holdings Inc
NASDAQ:GDRX
Country US
Market Cap 2.7B USD
Operating Margin
-4%

Profitability Report

View the profitability report to see the full profitability analysis for Pear Therapeutics Inc.

Full Profitability Report

See Also

Summary
PEAR intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEAR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEAR stock valuation using valuation multiples.
Wall Street Estimates
PEAR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEAR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-923%
=
Operating Profit
-117.2m
/
Revenue
12.7m
What is the Operating Margin of Pear Therapeutics Inc?

Based on Pear Therapeutics Inc's most recent financial statements, the company has Operating Margin of -923%.

ALPHA SPREAD
Join more than 141,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.